Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis

This study aimed to explore the current evidence on preventing blood-borne virus infections among people who inject drugs (PWID). We conducted a comprehensive search across three databases (PubMed, Embase, Cochrane Library) for relevant articles published in English between 2014 and 2023. We followe...

Full description

Bibliographic Details
Main Authors: Yen-Ju Chen, Yu-Chen Lin, Meng-Tien Wu, Jenn-Yuan Kuo, Chun-Hsiang Wang
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/16/1/142
_version_ 1797342398905319424
author Yen-Ju Chen
Yu-Chen Lin
Meng-Tien Wu
Jenn-Yuan Kuo
Chun-Hsiang Wang
author_facet Yen-Ju Chen
Yu-Chen Lin
Meng-Tien Wu
Jenn-Yuan Kuo
Chun-Hsiang Wang
author_sort Yen-Ju Chen
collection DOAJ
description This study aimed to explore the current evidence on preventing blood-borne virus infections among people who inject drugs (PWID). We conducted a comprehensive search across three databases (PubMed, Embase, Cochrane Library) for relevant articles published in English between 2014 and 2023. We followed the Preferred Reporting Items for Systematic Reviews and Meta Analysis (PRISMA) guidelines, assessed the quality of the paper using the revised Cochrane Risk of Bias Tool (ROB 2), and conducted a meta-analysis using RevMan 5.3. Completing the harm reduction program (HRP) participation and receiving all three vaccine doses resulted in a 28% reduction in the risk of HBV infection (OR: 0.72, 95% CI: 0.37–1.42). Various interventions increased the willingness of PWIDs to undergo HCV treatment (OR: 5.91, 95% CI: 2.46–14.24) and promoted treatment adherence (OR: 15.04, 95% CI: 2.80–80.61). Taking PrEP, participating in HRP, and modifying risky behaviors were associated with a 33% reduction in the risk of HIV infection (OR: 0.67, 95% CI: 0.61–0.74). Conducting referrals, providing counseling, and implementing antiretroviral therapy resulted in a 44% reduction in the risk of viral transmission (OR: 0.56, 95% CI: 0.47–0.66). Co-infection may potentially compromise effectiveness, so it is important to consider drug resistance.
first_indexed 2024-03-08T10:32:43Z
format Article
id doaj.art-a907785e3f314ee091f4fc1f08320f6f
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-08T10:32:43Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-a907785e3f314ee091f4fc1f08320f6f2024-01-26T18:48:34ZengMDPI AGViruses1999-49152024-01-0116114210.3390/v16010142Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-AnalysisYen-Ju Chen0Yu-Chen Lin1Meng-Tien Wu2Jenn-Yuan Kuo3Chun-Hsiang Wang4Research Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanResearch Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanResearch Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanDepartment of Hepatogastroenterology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanDepartment of Hepatogastroenterology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanThis study aimed to explore the current evidence on preventing blood-borne virus infections among people who inject drugs (PWID). We conducted a comprehensive search across three databases (PubMed, Embase, Cochrane Library) for relevant articles published in English between 2014 and 2023. We followed the Preferred Reporting Items for Systematic Reviews and Meta Analysis (PRISMA) guidelines, assessed the quality of the paper using the revised Cochrane Risk of Bias Tool (ROB 2), and conducted a meta-analysis using RevMan 5.3. Completing the harm reduction program (HRP) participation and receiving all three vaccine doses resulted in a 28% reduction in the risk of HBV infection (OR: 0.72, 95% CI: 0.37–1.42). Various interventions increased the willingness of PWIDs to undergo HCV treatment (OR: 5.91, 95% CI: 2.46–14.24) and promoted treatment adherence (OR: 15.04, 95% CI: 2.80–80.61). Taking PrEP, participating in HRP, and modifying risky behaviors were associated with a 33% reduction in the risk of HIV infection (OR: 0.67, 95% CI: 0.61–0.74). Conducting referrals, providing counseling, and implementing antiretroviral therapy resulted in a 44% reduction in the risk of viral transmission (OR: 0.56, 95% CI: 0.47–0.66). Co-infection may potentially compromise effectiveness, so it is important to consider drug resistance.https://www.mdpi.com/1999-4915/16/1/142prevention strategiesblood-borne virus infectionpeople who inject drugs (PWID)systematic reviewmeta-analysis
spellingShingle Yen-Ju Chen
Yu-Chen Lin
Meng-Tien Wu
Jenn-Yuan Kuo
Chun-Hsiang Wang
Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis
Viruses
prevention strategies
blood-borne virus infection
people who inject drugs (PWID)
systematic review
meta-analysis
title Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis
title_full Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis
title_fullStr Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis
title_full_unstemmed Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis
title_short Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis
title_sort prevention of viral hepatitis and hiv infection among people who inject drugs a systematic review and meta analysis
topic prevention strategies
blood-borne virus infection
people who inject drugs (PWID)
systematic review
meta-analysis
url https://www.mdpi.com/1999-4915/16/1/142
work_keys_str_mv AT yenjuchen preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis
AT yuchenlin preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis
AT mengtienwu preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis
AT jennyuankuo preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis
AT chunhsiangwang preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis